Status:
UNKNOWN
PRevention of INteractions Between Phytotherapies and CancEr Treatments by a SmartphonE/Tablet Automated SurvEy
Lead Sponsor:
Paul Gougis
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The use of phytotherapies or specific food or dietary supplement (HFDS) is common among cancer patients. They can also be responsible of clinically relevant interaction with anti-cancer treatments. Th...
Detailed Description
The use of herbal treatment, also called phytotherapies, or dietary supplements or specific food (herbs, food or dietary supplements HFDS) is very common and have been evaluated between 30 and 70%, de...
Eligibility Criteria
Inclusion
- Men or women over 18 years old
- Subject currently receiving a treatment for cancer or who has a planned treatment (radiotherapy, surgery, chemotherapy, hormonotherapy, targeted therapy or other procedure)
Exclusion
- The subject is not able to read
- The subject is not using any herb, food or dietary supplement with a daily consumption.
- The subject refuses to be part of the study
- The subject does not know the name of the anticancer therapy that he receives.
- The subject does not know if he uses either phytotherapy, specific food consumed daily or dietary supplements.
Key Trial Info
Start Date :
April 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 11 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04128865
Start Date
April 13 2018
End Date
November 11 2019
Last Update
October 16 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'Investigation Clinique Paris-Est
Paris, France, 75013
2
Centre d'Investigation Clinique Paris-Est
Paris, France, 75013